Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disorders, Lymphoproliferative”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT00900198
What this trial is testing

Collection of Tissue Samples for Cancer Research

Who this might be right for
NeoplasmsLymphomasMultiple Myeloma+1 more
National Cancer Institute (NCI) 5,000
Not applicableNot Yet RecruitingNCT06721598
What this trial is testing

An Extension Study to Evaluate the Safety and Efficacy of an Anti-CD19 CAR-T Product in Patients with B-cell Lymphoproliferative Disorders

Who this might be right for
Non-Hodgkin Lymphoma, B-cellAcute Lymphoblastic Leukemia ALL
National Research Center for Hematology, Russia 60
Not applicableStudy completedNCT02294487
What this trial is testing

Study of the Immune Response After Vaccination in Multiple Myeloma Patients

Who this might be right for
Multiple MyelomaMyeloma, MultipleMyeloma-Multiple
Wake Forest University Health Sciences 19
Testing effectiveness (Phase 2)Looking for participantsNCT05469893
What this trial is testing

Immuno-PRISM (PRecision Intervention Smoldering Myeloma)

Who this might be right for
High-risk Smoldering Multiple MyelomaSmoldering Multiple MyelomaMultiple Myeloma
Irene Ghobrial, MD 52
Early research (Phase 1)Study completedNCT02175433
What this trial is testing

Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Doses of AGS67E Given as Monotherapy in Subjects With Refractory or Relapsed Lymphoid Malignancies

Who this might be right for
Relapsed Lymphoid MalignancyRefractory Lymphoid Malignancy
Astellas Pharma Global Development, Inc. 71
Large-scale testing (Phase 3)Study completedNCT00136552
What this trial is testing

Study for Newly Diagnosed Follicular Lymphoma Patients With a Large Tumor Burden

Who this might be right for
Lymphoma
Lymphoma Study Association 360
Testing effectiveness (Phase 2)Active Not RecruitingNCT03556332
What this trial is testing

Carfilzomib, Lenalidomide, Dexamethasone and Daratumumab for Patients With Relapsed/Refractory Myeloma With Salvage Autologous Hematopoietic Cell Transplantation

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 41
Not applicableNot Yet RecruitingNCT04702932
What this trial is testing

Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaWaldenstrom Macroglobulinemia
Assistance Publique - Hôpitaux de Paris 30
Not applicableNot Yet RecruitingNCT05969821
What this trial is testing

Clonal Hematopoiesis of Immunological Significance

Who this might be right for
Immune System DiseasesAutoimmune DiseasesInflammation+13 more
Assistance Publique - Hôpitaux de Paris 5,000
Testing effectiveness (Phase 2)Study completedNCT00002652
What this trial is testing

Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's Disease

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
University of Arkansas
Testing effectiveness (Phase 2)Study completedNCT01599949
What this trial is testing

Evaluate the Efficacy and Safety of Ibrutinib, in Patients With Mantle Cell Lymphoma Who Progress After Bortezomib Therapy

Who this might be right for
Mantle Cell Lymphoma
Janssen Research & Development, LLC 120
Not applicableUnknownNCT05360758
What this trial is testing

Ibrutinib Adapted to Response in Patients With CLL

Who this might be right for
Chronic Lymphocytic Leukemia
Grupo Argentino de Tratamiento de la Leucemia Aguda 80
Testing effectiveness (Phase 2)Looking for participantsNCT06846463
What this trial is testing

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

Who this might be right for
Diffuse Large B-cell LymphomaDLBCL - Diffuse Large B Cell Lymphoma
Virginia Commonwealth University 21
Not applicableUnknownNCT05793463
What this trial is testing

Anti-mullerian Hormone in Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia
IRCCS Burlo Garofolo 10
Early research (Phase 1)UnknownNCT00023816
What this trial is testing

Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00004084
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Who this might be right for
LeukemiaLymphoma
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 21
Testing effectiveness (Phase 2)Study completedNCT01392716
What this trial is testing

MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 48
Not applicableWithdrawnNCT04641806
What this trial is testing

Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma

Who this might be right for
B-cell LymphomaCovid19
Versailles Hospital
Testing effectiveness (Phase 2)Study completedNCT03322384
What this trial is testing

UCDCC#271: Phase I/II Trial of Epacadostat, Intralesional SD101, Radiotherapy in Patients With Lymphoma

Who this might be right for
Advanced Solid TumorsLymphoma
University of California, Davis 20
Testing effectiveness (Phase 2)Study completedNCT00866749
What this trial is testing

Augmented Berlin-Frankfurt-Munster (BFM) Therapy for Adolescent/Young Adults With Acute Lymphoblastic Leukemia or Acute Lymphoblastic Lymphoma

Who this might be right for
Lymphoblastic LeukemiaLymphoblastic Lymphoma
M.D. Anderson Cancer Center 120
Next Page